Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (101-110 of 272) with videos related to

Pageof 28
Sort By:
Journal of Translational Medicine|May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) studySandro Pignata, Enrico Breda, Giovanni Scambia, et al.
International Journal of Molecular Sciences|September 22, 2017
Angiogenesis Inhibitors in NSCLCAnna Manzo, Agnese Montanino, Guido Carillio, et al.
Cancer|March 29, 2002
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II studyAndrea de Matteis, Francesco Nuzzo, Giuseppe D'Aiuto, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic reviewClizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
The Lancet. Oncology|May 7, 2003
Statistical design in phase II clinical trials and its application in breast cancerFrancesco Perrone, Massimo Di Maio, Ermelinda De Maio, et al.
Journal of Clinical Gastroenterology|February 19, 2003
First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II studyBruno Daniele, Gerardo Rosati, Rosa Tambaro, et al.
BMJ Open|December 13, 2019
Anticancer drug prices and clinical outcomes: a cross-sectional study in ItalyFrancesco Trotta, Flavia Mayer, Francesco Barone-Adesi, et al.
Journal of Cancer Policy|April 23, 2025
Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impactAnna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, et al.
JCO Precision Oncology|November 9, 2023
Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific SocietiesGianpiero Fasola, Maria C Barducci, Valeria D Tozzi, et al.
Pageof 28

Showing results (101-110 of 272) with videos related to

Sort By:
Pageof 28
Journal of Translational Medicine|May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) studySandro Pignata, Enrico Breda, Giovanni Scambia, et al.
International Journal of Molecular Sciences|September 22, 2017
Angiogenesis Inhibitors in NSCLCAnna Manzo, Agnese Montanino, Guido Carillio, et al.
Cancer|March 29, 2002
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II studyAndrea de Matteis, Francesco Nuzzo, Giuseppe D'Aiuto, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic reviewClizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
The Lancet. Oncology|May 7, 2003
Statistical design in phase II clinical trials and its application in breast cancerFrancesco Perrone, Massimo Di Maio, Ermelinda De Maio, et al.
Journal of Clinical Gastroenterology|February 19, 2003
First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II studyBruno Daniele, Gerardo Rosati, Rosa Tambaro, et al.
BMJ Open|December 13, 2019
Anticancer drug prices and clinical outcomes: a cross-sectional study in ItalyFrancesco Trotta, Flavia Mayer, Francesco Barone-Adesi, et al.
Journal of Cancer Policy|April 23, 2025
Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impactAnna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, et al.
JCO Precision Oncology|November 9, 2023
Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific SocietiesGianpiero Fasola, Maria C Barducci, Valeria D Tozzi, et al.
Pageof 28